Abstract

The utilization of cannabis subsequent to the onset of first-episode psychosis has been associated with heightened risks of relapse and non-adherence to antipsychotic medication. However, it remains unclear whether the adverse impact of cannabis on medication adherence directly contributes to the unfavorable outcomes linked with cannabis use. There is a possibility that interventions aimed at improving medication adherence could partially alleviate the negative effects of cannabis use in individuals experiencing psychosis.